EP 3386993 A1 20181017 - SUBSTITUTED PERHYDROPYRROLO[3,4-C]PYRROLE DERIVATIVES AND THEIR USE
Title (en)
SUBSTITUTED PERHYDROPYRROLO[3,4-C]PYRROLE DERIVATIVES AND THEIR USE
Title (de)
SUBSTITUIERTE PERHYDROPYRROLO[3,4-C]PYRROL-DERIVATE UND IHRE VERWENDUNG
Title (fr)
DÉRIVÉS DES PERHYDROPYRROLO[3,4-C]PYRROLES SUBSTITUÉES ET LEUR UTILISATION
Publication
Application
Priority
- EP 15199268 A 20151210
- EP 2016079544 W 20161202
Abstract (en)
[origin: WO2017097671A1] The invention relates to novel (2-phenylimidazo[1,2-a]pyridin-3-yl)methyl-substituted perhydropyrrolo[3,4-c]pyrrole derivatives, to methods for producing same, to the use thereof alone or in combination for the treatment and/or prevention of diseases, and to the use thereof for producing drugs for the treatment and/or prevention of diseases, especially for the treatment and/or prevention of breathing disorders including sleep-related breathing disorders such as obstructive and central sleep apnea and snoring.
IPC 8 full level
C07D 519/00 (2006.01); A61K 31/437 (2006.01); A61P 11/00 (2006.01)
CPC (source: EP US)
A61K 31/437 (2013.01 - EP US); A61K 45/06 (2013.01 - US); A61P 11/00 (2017.12 - EP US); C07D 471/04 (2013.01 - EP US); C07D 519/00 (2013.01 - EP US)
Citation (search report)
See references of WO 2017097671A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2017097671 A1 20170615; CA 3007699 A1 20170615; CN 108699084 A 20181023; EP 3386993 A1 20181017; JP 2018538296 A 20181227; US 10414765 B2 20190917; US 2018370965 A1 20181227
DOCDB simple family (application)
EP 2016079544 W 20161202; CA 3007699 A 20161202; CN 201680081569 A 20161202; EP 16805135 A 20161202; JP 2018530094 A 20161202; US 201615781848 A 20161202